EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma

Osamu Gotoh iD, Yuko Sugiyama, Akiko Tonooka, Mayuko Kosugi, Sunao Kitaura, Ryu Minegishi, Masatoshi Sano, Sayuri Amino, Rie Furuya, Norio Tanaka iD, Tomoko Kaneyasu, Kohei Kumegawa und 7 weitere

The Journal of Pathology · 2024-07 · 263 (3) · 275-287

DOI: 10.1002/path.6278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 11.05.2024. Verfasst von Osamu Gotoh und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Carcinoma, Endometrioid, Epigenesis, Genetic, DNA Methylation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, The Vehicle Racing Commemorative Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hyperplasia–carcinoma sequence is a stepwise tumourigenic programme towards endometrial cancer in which normal endometrial epithelium becomes neoplastic through non‐atypical endometrial hyperplasia (NAEH) and atypical endometrial hyperplasia (AEH), under the influence of unopposed oestrogen. NAEH and AEH are known to exhibit polyclonal and monoclonal cell growth, respectively; yet, aside from focal PTEN protein loss, the genetic and epigenetic alterations that occur during the cellular transition remain largely unknown. We sought to explore the potential molecular mechanisms that promote the NAEH–AEH transition and identify molecular markers that could help to differentiate between these two states. We conducted target‐panel sequencing on the coding exons of 596 genes, including 96 endometrial cancer driver genes, and DNA methylome microarrays for 48 NAEH and 44 AEH lesions that were separately collected via macro‐ or micro‐dissection from the endometrial tissues of 30 cases. Sequencing analyses revealed acquisition of the PTEN mutation and the clonal expansion of tumour cells in AEH samples. Further, across the transition, alterations to the DNA methylome were characterised by hypermethylation of promoter/enhancer regions and CpG islands, as well as hypo‐ and hyper‐methylation of DNA‐binding regions for transcription factors relevant to endometrial cell differentiation and/or tumourigenesis, including FOXA2, SOX17, and HAND2. The identified DNA methylation signature distinguishing NAEH and AEH lesions was reproducible in a validation cohort with modest discriminative capability. These findings not only support the concept that the transition from NAEH to AEH is an essential step within neoplastic cell transformation of endometrial epithelium but also provide deep insight into the molecular mechanism of the tumourigenic programme. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsCarcinoma, EndometrioidEpigenesis, GeneticDNA MethylationPTEN PhosphohydrolaseEndometrial HyperplasiaFemaleHumansPrecancerous ConditionsMutationGene Expression Regulation, NeoplasticMiddle AgedBiomarkers, TumorCpG IslandsAged

Stichwörter der Autor:innen

DNA methylomeatypical endometrial hyperplasiadriver genesendometrial cancerendometrial cell differentiationendometrial endometrioid carcinomamutationneoplastic cell transformationnon‐atypical endometrial hyperplasia

Substanzen

PTEN PhosphohydrolasePTEN protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Japan.
  • Division of Gynecology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Japan.
  • Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Japan.
  • Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Japan.
  • Department of Pathology, Toranomon Hospital, Minato-ku, Japan.
  • Department of Genetic Diagnosis, Cancer Institute Hospital, JFCR, Koto-ku, Japan.

ORCID-Profile: Osamu Gotoh, Norio Tanaka

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • The Vehicle Racing Commemorative Foundation

Zitieren

APA

Gotoh, O., Sugiyama, Y., Tonooka, A., Kosugi, M., Kitaura, S., Minegishi, R., Sano, M., Amino, S., Furuya, R., Tanaka, N., Kaneyasu, T., Kumegawa, K., Abe, A., Nomura, H., Takazawa, Y., Kanao, H., Maruyama, R., Noda, T., & Mori, S. (2024). Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma. The Journal of Pathology, 263(3), 275-287. https://doi.org/10.1002/path.6278

Vancouver

Gotoh O, Sugiyama Y, Tonooka A, Kosugi M, Kitaura S, Minegishi R, et al. Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma. The Journal of Pathology. 2024;263(3):275-287. doi:10.1002/path.6278

BibTeX
@article{Gotoh2024,
  author = {Gotoh, Osamu and Sugiyama, Yuko and Tonooka, Akiko and Kosugi, Mayuko and Kitaura, Sunao and Minegishi, Ryu and Sano, Masatoshi and Amino, Sayuri and Furuya, Rie and Tanaka, Norio and Kaneyasu, Tomoko and Kumegawa, Kohei and Abe, Akiko and Nomura, Hidetaka and Takazawa, Yutaka and Kanao, Hiroyuki and Maruyama, Reo and Noda, Tetsuo and Mori, Seiichi},
  title = {Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma},
  journal = {The Journal of Pathology},
  year = {2024},
  volume = {263},
  number = {3},
  pages = {275--287},
  doi = {10.1002/path.6278}
}
Kostenlos starten →